Beckman Coulter Diagnostics DxN VERIS Molecular Diagnostics System* has the Potential to Positively Impact Clinical Service Delivery
Findings from Sheffield Teaching Hospitals NHS Trust
Findings from Sheffield Teaching Hospitals NHS Trust
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumor cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis
Joins Dr. Beckman and Wallace Coulter as Fellows of American Institute for Medical and Biological Engineering (AIMBE)
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
iPLEX® HS chemistry enables multiplex detection down to 1% allele frequency
BMG LABTECH’s readers are used to measure binding kinetics over minutes
New platform enables researchers to rapidly identify cutting-edge anti-cancer drugs
Researchers’ use of ParsortixTM System for studies into multiple cancers confirms the cell separation technology’s ability to harvest viable circulating tumor cells for a broad range of downstream analyses
Numerous factors can introduce error into lab processes that lead to Out-of-Specification results—including manual sample processing using flasks. A new article from METTLER TOLEDO explores 10 compelling reasons to leave error-prone manual workflows behind and create greater accuracy and efficiency in routine sample preparation.
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
DxN VERIS Molecular Diagnostics System Showcasing on Booth #52 and at Symposium
The CDMO secures the accolade for a sixth time through its talented personnel
Digital flow morphology delivers workflow improvements, reducing the need for manual microscope review
In vitro diagnostic approved to support use of Bristol-Myers Squibb’s OPDIVO® for non-squamous non-small cell lung cancer
Microwave Technology Applied To Inorganic Synthesis: What Is Going To Change?